Vimta Labs cash flow

·Pharma & HealthChart ›
Latest FY26
Cash from operations
₹147cr+55.5% on FY25
Capital spending
₹99.8cr+25.5% on FY25
Free cash flow
₹47.3cr+213.1% on FY25
Cash from financing
−₹10.4cr−₹16.7 cr in FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Adjustments to reconcile profit — non-cash items
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
—43.835.734.030.5
—5.01.91.64.1
—−0.7−0.1−0.2−0.2
—4.9−2.02.44.4
—0.01.40.00.0
Changes in working capital
—−4.9−0.4−2.1−5.2
—−4.7−21.8−10.0−7.2
—−0.00.20.00.0
—0.00.01.1−2.4
—1.9−3.00.00.0
—0.00.00.3−0.6
—0.61.7−6.32.0
—1.07.30.27.9
—21.38.12.11.5
—0.0−0.10.00.0
Cash from operating activities
10710489.051.563.8
—68.028.823.034.8
—17211874.698.6
—−2.7−1.6−1.3−1.2
—−0.5−1.6−1.7−2.2
—1.1−1.2−1.0−0.8
—23.722.014.812.2
—14794.659.186.5
Cash from investing activities
—99.779.175.247.8
—0.10.40.22.0
—0.10.02.10.2
—0.02.90.00.0
—32.00.00.00.0
—0.04.50.00.0
—0.00.0−0.2−0.2
—2.01.31.51.0
—0.0−4.8−3.1−8.6
—−130−75.5−74.6−56.9
Cash from financing activities
—0.00.00.00.0
—0.00.00.00.0
—0.00.79.20.0
—5.411.75.25.4
—0.51.31.50.9
—4.54.44.44.4
—−10.4−16.7−1.9−10.7
—7.12.4−17.418.9
—0.00.00.00.0
—7.12.4−17.418.9
———12.129.6
Reference items
14514212283.693.5
34.7%34.8%35.5%26.7%29.7%
47.347.315.1−16.336.7
—41.63.1−13.6—
₹10.60₹10.60₹3.38−₹3.66₹8.22
49.05×————
—1.90×1.40×1.52×1.83×
—23.722.014.812.2
—0.51.31.50.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

VIMTALABS₹519.80

Vimta Labs Limited

· Pharma & Health
₹ CrorePeersSUVENTAKEMcap ₹2,322 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation30.534.035.743.8—
+ Share-based Payments4.11.61.95.0—
+ Unrealised FX (Gain) / Loss-0.2-0.2-0.1-0.7—
+ Other Non-cash Items4.42.4-2.04.9—
+ Other Reconciling Items0.00.01.40.0—
Changes in Working Capital
+ Inventories-5.2-2.1-0.4-4.9—
+ Trade Receivables — Current-7.2-10.0-21.8-4.7—
+ Other Financial Assets — Current0.00.00.2-0.0—
+ Other Financial Assets — Non-current-2.41.10.00.0—
+ Other Current Assets0.00.0-3.01.9—
+ Other Non-current Assets-0.60.30.00.0—
+ Trade Payables — Current2.0-6.31.70.6—
+ Other Financial Liabilities — Current7.90.27.31.0—
+ Other Current Liabilities1.52.18.121.3—
+ Provisions — Current0.00.0-0.10.0—
Cash from Operating Activities
Profit Before Tax (per I/S)63.851.589.0104.0107.0
+ Total Adjustments (incl. Working Capital)34.823.028.868.0—
Cash from Operations (pre-tax)98.674.6117.8171.9—
+ Interest Received — Operating-1.2-1.3-1.6-2.7—
+ Interest Paid — Operating-2.2-1.7-1.6-0.5—
+ Other Inflows / (Outflows) — Operating-0.8-1.0-1.21.1—
+ Income Taxes Paid12.214.822.023.7—
Cash from Operating Activities86.559.194.6147.1—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)47.875.279.199.7—
+ Acq of Intangible Assets2.00.20.40.1—
+ Disp of Fixed Assets0.22.10.00.1—
+ Disp of Investment Property0.00.02.90.0—
+ Acq of Other Long-term Assets0.00.00.032.0—
+ Disp of Subsidiaries / Businesses (net)0.00.04.50.0—
+ Loans & Advances Made-0.2-0.20.00.0—
+ Interest Received — Investing1.01.51.32.0—
+ Other Inflows / (Outflows) — Investing-8.6-3.1-4.80.0—
Cash from Investing Activities-56.9-74.6-75.5-129.7—
Cash from Financing Activities
+ Proceeds from Issue of Shares0.00.00.00.0—
+ Proceeds from Exercise of Stock Options0.00.00.00.0—
+ Proceeds from Borrowings0.09.20.70.0—
+ Repayment of Borrowings5.45.211.75.4—
+ Interest Paid0.91.51.30.5—
+ Dividends Paid4.44.44.44.5—
Cash from Financing Activities-10.7-1.9-16.7-10.4—
Net Changes in Cash (pre-FX)18.9-17.42.47.1—
+ Effect of FX Rate Changes on Cash0.00.00.00.0—
Net Changes in Cash18.9-17.42.47.1—
Closing Cash29.612.1———
Reference Items
EBITDA93.583.6121.9141.5145.1
EBITDA Margin %29.6926.7335.4534.7534.66
Free Cash Flow (CFO − Capex)36.7-16.315.147.347.3
Free Cash Flow to Equity—-13.63.141.6—
Free Cash Flow per Basic Share8.22-3.663.3810.6010.60
Price to Free Cash Flow————49.05
Cash Flow to Net Income1.831.521.401.90—
Cash Paid for Taxes12.214.822.023.7—
Cash Paid for Interest0.91.51.30.5—
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.